EGLN1 and osteonecrosis: These results suggest that YGY decoction effectively counteracts oxidative damage caused by glucocorticoids to achieve therapeutic effects in treating osteonecrosis, which is achieved by modulating the ROS/PHD2/HIF-1α signaling pathway (Fig. 9).